Pàgina inicial > Resultats de la cerca: Devaux, Yvan
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
50 p, 1.3 MB CARDIOVASCULAR RNA MARKERS AND ARTIFICIAL INTELLIGENCE MAY IMPROVE COVID-19 OUTCOME : POSITION PAPER FROM THE EU-CardioRNA COST Action CA17129 / Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Robinson, Emma L. (Maastricht University) ; Jusic, Amela (Cardiovascular Research Unit) ; Carpusca, Irina (Cardiovascular Research Unit) ; de Windt, Leon J.. (Department of Molecular Genetics) ; Emanueli, Costanza (National Heart & Lung Institute) ; Ferdinandy, Péter (Cardiometabolic Research Group and MTA-SE System Pharmacology Research Group) ; Gu, Wei (Luxembourg Center for Systems Biomedicine) ; Gyöngyösi, Mariann (Department of Cardiology) ; Hackl, Matthias (TAmiRNA GmbH) ; Karaduzovic-Hadziabdic, Kanita (Faculty of Engineering and Natural Sciences) ; Lustrek, Mitja (Department of Intelligent Systems) ; Martelli, Fabio (Molecular Cardiology Laboratory) ; Nham, Eric (University of Zagreb School of Medicine) ; Potočnjak, Ines (Institute for Clinical Medical Research and Education) ; Satagopam, Venkata (Luxembourg Center for Systems Biomedicine) ; Schneider, Reinhard (Luxembourg Center for Systems Biomedicine) ; Thum, Thomas (Institute of Molecular and Translational Therapeutic Strategies (IMTTS)) ; Devaux, Yvan (Cardiovascular Research Unit) ; Universitat Autònoma de Barcelona
The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of February 8th, 2020 and causing more than 2. 3 million deaths according the World Health Organization. [...]
2021 - 10.1093/cvr/cvab094
Cardiovascular research, april 2021  
Registre complet - Creative Commons
2.
12 p, 975.8 KB Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock / Hänninen, Mikko (Minerva Foundation Institute for Medical Research (Finland)) ; Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ; Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ; Segersvärd, Heli (Minerva Foundation Institute for Medical Research (Finland)) ; Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ; Lassus, Johan (Helsinki University Hospital (Finlàndia)) ; Vausort, Mélanie (Luxembourg Institute of Health) ; Devaux, Yvan (Luxembourg Institute of Health) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Tikkanen, Ilkka (Helsinki University Hospital (Finlàndia)) ; Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ; Lakkisto, Päivi (Helsinki University Hospital (Finlàndia)) ; Universitat Autònoma de Barcelona
Cardiogenic shock (CS) is a life-threatening emergency. New biomarkers are needed in order to detect patients at greater risk of adverse outcome. Our aim was to assess the characteristics of miR-21-5p, miR-122-5p, and miR-320a-3p in CS and evaluate the value of their expression levels in risk prediction. [...]
2020 - 10.3390/ijms21217925
International journal of molecular sciences, Vol. 21 (october 2020)  
Registre complet - Creative Commons
3.
5 p, 173.0 KB Circulating levels of 423-5p are associated with 90 day mortality in cardiogenic shock / Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ; Segersvärd, Heli (Minerva Foundation Institute for Medical Research and University of Helsinki) ; Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ; Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ; Lassus, Johan (Helsinki University Hospital (Finlàndia)) ; Devaux, Yvan (Luxembourg Institute of Health) ; Vausort, Mélanie (Luxembourg Institute of Health) ; Pulkki, Kari (Department of Clinical Chemistry, University of Eastern Finland and Eastern Finland Laboratory Centre (ISLAB)) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tikkanen, Ilkka (Helsinki University Hospital (Finlàndia)) ; Lakkisto, Päivi (Helsinki University Hospital (Finlàndia)) ; Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ; Universitat Autònoma de Barcelona. Departament de Medicina
The role of microRNAs has not been studied in cardiogenic shock. We examined the potential role of miR-423-5p level to predict mortality and associations of miR-423-5p with prognostic markers in cardiogenic shock. [...]
2018 - 10.1002/ehf2.12377
ESC Heart Failure, Vol. 6 (november 2018) , p. 98-102  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem